Predict your next investment

Biofourmis company logo
Corporation
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Healthcare
biofourmis.com

See what CB Insights has to offer

Total Raised

$141.85M

Investors Count

12

Deal Terms

1

Biofourmis Funding, Biofourmis Valuation & Biofourmis Revenue

5 Fundings

Biofourmis's latest funding round was a Series C for $100M on September 2, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/2/2020

Series C

$100M

7

5/3/2020

Loan

$99M

0

5/21/2019

Series B

$99M

10

12/11/2017

Series A

$99M

10

8/10/2016

Seed

$99M

10

Date

9/2/2020

5/3/2020

5/21/2019

12/11/2017

8/10/2016

Round

Series C

Loan

Series B

Series A

Seed

Amount

$100M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

Sources

7

0

10

10

10

Biofourmis Deal Terms

1 Deal Term

Biofourmis's deal structure is available for 1 funding round, including their Series A from December 11, 2017.

Round

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series A

$99M

$99M

$99M

$99M

Biofourmis Investors

12 Investors

Biofourmis has 12 investors. OpenSpace Ventures invested in Biofourmis's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/11/2017

9/2/2020

3
Series A, Series B (2019), Series C (2020)

Venture Capital

Singapore

5/21/2019

9/2/2020

2
Series B, Series C (2020)

Corporate Venture

Massachusetts

5/21/2019

9/2/2020

2
Series B, Series C (2020)

Asset/Investment Management

Singapore

00/00/0000

00/00/0000

SoftBank Group

Subscribe to see more

Holding Company

Japan

00/00/0000

00/00/0000

Sequoia Capital

Subscribe to see more

Venture Capital

California

First funding

12/11/2017

5/21/2019

5/21/2019

00/00/0000

00/00/0000

Last Funding

9/2/2020

9/2/2020

9/2/2020

00/00/0000

00/00/0000

Investor

SoftBank Group

Sequoia Capital

Rounds

3
Series A, Series B (2019), Series C (2020)
2
Series B, Series C (2020)
2
Series B, Series C (2020)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Corporate Venture

Asset/Investment Management

Holding Company

Venture Capital

Location

Singapore

Massachusetts

Singapore

Japan

California

Biofourmis Acquisitions

2 Acquisitions

Biofourmis acquired 2 companies. Their latest acquisition was Gaido Health on April 16, 2020.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/16/2020

$99M

Acquired - II

3

11/18/2019

Series A

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

4/16/2020

11/18/2019

Investment Stage

Series A

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$99M

Note

Acquired - II

Subscribe to see more

Sources

3

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.